Clinical Research Directory
Browse clinical research sites, groups, and studies.
Extended Therapeutic Effect of 35kDa Hyaluronan Fragment Injection in Patients With Chronic Pain Caused by Myofascial Pain Syndrome
Sponsor: Nakhia Impex LLC
Summary
To verify the efficacy and safety of HA35 in chronic pain management and to further supplement effective treatments for chronic pain, we designed a proof-of-concept clinical study. This study aims to evaluate the 15-day treatment of HA35 on patients with myofascial pain syndrome and to observe the effects for up to 3 months.
Official title: 35kDa Hyaluronan Fragment Injection Treatment Myofascial Pain Syndrome
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
10
Start Date
2024-05-30
Completion Date
2024-12
Last Updated
2024-06-06
Healthy Volunteers
No
Conditions
Interventions
HA35 injection
HA35/B-HA injection (Registration number L20200708MP07707; Ministry of Health). The subjects can continue to take oral analgesics during the treatment period, and the comparison of the dose and interval days of the analgesics before and after the treatment can also be used as the effect judgment of the injection.
Locations (1)
Nahia Impex Llc
Ulaanbaatar, Mongolia